<DOC>
	<DOCNO>NCT00195234</DOCNO>
	<brief_summary>The purpose study learn whether study vaccine adjuvant ( drug use help improve immune response ) acceptable safety profile treat individual HIV . A second purpose study understand immune system respond study vaccine adjuvant .</brief_summary>
	<brief_title>Study Evaluating Vaccine Adults With HIV</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>18 year age diagnose HIV stable HAART minimum six month CD4 Tcell count great equal 350/mm3 screening No report CD4 Tcell count le 350/mm3 time screen Viral load le 50 copies/mL screen viral load great 400 copies/mL minimum six month prior screen Any chronic symptomatic infection HIV Use prior HIV vaccine ( prophylactic and/or therapeutic ) within one year screen Any malignancy may require systemic therapy Use investigational treatment within six month screen plan study enrollment , except investigational retrovirals obtain ACTG</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>HIV</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>